Influenza Vaccine Market Outlook: Size, Share, Trends, Growth Analysis, Competitive Landscape & Forecast, 2026-2033

The Influenza Vaccine Market size was valued at US$ 9.66 Billion in 2025 and is projected to reach US$ 23.46 Billion by 2033, growing at a CAGR of 11.73% during 2026–2033, driven by vaccination programs, strain updates, manufacturing innovation, pediatric coverage, adult immunization, and emerging regional supply opportunities.

Report Coverage

Type: Inactivated, Live Attenuated
Valency: Quadrivalent, Trivalent
Age Group: Pediatric, Adults
Distribution Channel: Hospital & Retail Pharmacies, Government Suppliers, Others

US$ 9.66 Bn Market size in 2025

US$ 23.46 Bn Market Size by 2033

11.73% CAGR, 2026 - 2033

2026-2033 Forecast Period

Download Sample PDF Buy Now

Format PDF + Excel + PPT

No. of Pages: 350

Category Life Sciences

Report Code: BMIPUB00039549

Last Updated: 2026-10-05

Author

Krishna Sunthwal

Analyst Connect

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Influenza Vaccine Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Influenza Vaccine Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Influenza Vaccine Market Global Analysis

6.2 Influenza Vaccine Market Revenue 2022-2033 (US$ Billion)

6.3 Influenza Vaccine Market Forecast Analysis

7. Influenza Vaccine Market Analysis – by Type

7.1 Inactivated

7.1.1 Overview
7.1.2 Inactivated: Influenza Vaccine Market – Revenue and Forecast, 2022-2033 (US$ Billion)

7.2 Live Attenuated

7.2.1 Overview
7.2.2 Live Attenuated: Influenza Vaccine Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8. Influenza Vaccine Market Analysis – by Valency

8.1 Quadrivalent

8.1.1 Overview
8.1.2 Quadrivalent: Influenza Vaccine Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8.2 Trivalent

8.2.1 Overview
8.2.2 Trivalent: Influenza Vaccine Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9. Influenza Vaccine Market Analysis – by Age Group

9.1 Pediatric

9.1.1 Overview
9.1.2 Pediatric: Influenza Vaccine Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9.2 Adults

9.2.1 Overview
9.2.2 Adults: Influenza Vaccine Market – Revenue and Forecast, 2022-2033 (US$ Billion)

10. Influenza Vaccine Market Analysis – by Distribution Channel

10.1 Hospital & Retail Pharmacies

10.1.1 Overview
10.1.2 Hospital & Retail Pharmacies: Influenza Vaccine Market – Revenue and Forecast, 2022-2033 (US$ Billion)

10.2 Government Suppliers

10.2.1 Overview
10.2.2 Government Suppliers: Influenza Vaccine Market – Revenue and Forecast, 2022-2033 (US$ Billion)

10.3 Others

10.3.1 Overview
10.3.2 Others: Influenza Vaccine Market – Revenue and Forecast, 2022-2033 (US$ Billion)

11. Influenza Vaccine Market – Geographic Analysis

11.1 Overview

11.2 North America

11.2.1 Influenza Vaccine Market Breakdown, by Key Country, 2026 and 2033 (%)
11.2.1.1 Influenza Vaccine Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.2.1.1.1 US: Influenza Vaccine Market Breakdown, by Type
11.2.1.1.2 US: Influenza Vaccine Market Breakdown, by Valency
11.2.1.1.3 US: Influenza Vaccine Market Breakdown, by Age Group
11.2.1.1.4 US: Influenza Vaccine Market Breakdown, by Distribution Channel

11.2.1.2 Canada: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.2.1.2.1 Canada: Influenza Vaccine Market Breakdown, by Type
11.2.1.2.2 Canada: Influenza Vaccine Market Breakdown, by Valency
11.2.1.2.3 Canada: Influenza Vaccine Market Breakdown, by Age Group
11.2.1.2.4 Canada: Influenza Vaccine Market Breakdown, by Distribution Channel

11.2.1.3 Mexico: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.2.1.3.1 Mexico: Influenza Vaccine Market Breakdown, by Type
11.2.1.3.2 Mexico: Influenza Vaccine Market Breakdown, by Valency
11.2.1.3.3 Mexico: Influenza Vaccine Market Breakdown, by Age Group
11.2.1.3.4 Mexico: Influenza Vaccine Market Breakdown, by Distribution Channel

11.3 Europe

11.3.1 Influenza Vaccine Market Breakdown, by Key Country, 2026 and 2033 (%)
11.3.1.1 Influenza Vaccine Market – Revenue and Forecast Analysis – by Country
11.3.1.1 Germany: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.1.1 Germany: Influenza Vaccine Market Breakdown, by Type
11.3.1.1.2 Germany: Influenza Vaccine Market Breakdown, by Valency
11.3.1.1.3 Germany: Influenza Vaccine Market Breakdown, by Age Group
11.3.1.1.4 Germany: Influenza Vaccine Market Breakdown, by Distribution Channel

11.3.1.2 Italy: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.2.1 Italy: Influenza Vaccine Market Breakdown, by Type
11.3.1.2.2 Italy: Influenza Vaccine Market Breakdown, by Valency
11.3.1.2.3 Italy: Influenza Vaccine Market Breakdown, by Age Group
11.3.1.2.4 Italy: Influenza Vaccine Market Breakdown, by Distribution Channel

11.3.1.3 France: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.3.1 France: Influenza Vaccine Market Breakdown, by Type
11.3.1.3.2 France: Influenza Vaccine Market Breakdown, by Valency
11.3.1.3.3 France: Influenza Vaccine Market Breakdown, by Age Group
11.3.1.3.4 France: Influenza Vaccine Market Breakdown, by Distribution Channel

11.3.1.4 U.K.: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.4.1 U.K.: Influenza Vaccine Market Breakdown, by Type
11.3.1.4.2 U.K.: Influenza Vaccine Market Breakdown, by Valency
11.3.1.4.3 U.K.: Influenza Vaccine Market Breakdown, by Age Group
11.3.1.4.4 U.K.: Influenza Vaccine Market Breakdown, by Distribution Channel

11.3.1.5 Spain: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.5.1 Spain: Influenza Vaccine Market Breakdown, by Type
11.3.1.5.2 Spain: Influenza Vaccine Market Breakdown, by Valency
11.3.1.5.3 Spain: Influenza Vaccine Market Breakdown, by Age Group
11.3.1.5.4 Spain: Influenza Vaccine Market Breakdown, by Distribution Channel

11.3.1.6 Belgium: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.6.1 Belgium: Influenza Vaccine Market Breakdown, by Type
11.3.1.6.2 Belgium: Influenza Vaccine Market Breakdown, by Valency
11.3.1.6.3 Belgium: Influenza Vaccine Market Breakdown, by Age Group
11.3.1.6.4 Belgium: Influenza Vaccine Market Breakdown, by Distribution Channel

11.3.1.7 Netherlands: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.7.1 Netherlands: Influenza Vaccine Market Breakdown, by Type
11.3.1.7.2 Netherlands: Influenza Vaccine Market Breakdown, by Valency
11.3.1.7.3 Netherlands: Influenza Vaccine Market Breakdown, by Age Group
11.3.1.7.4 Netherlands: Influenza Vaccine Market Breakdown, by Distribution Channel

11.3.1.8 Luxembourg: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.8.1 Luxembourg: Influenza Vaccine Market Breakdown, by Type
11.3.1.8.2 Luxembourg: Influenza Vaccine Market Breakdown, by Valency
11.3.1.8.3 Luxembourg: Influenza Vaccine Market Breakdown, by Age Group
11.3.1.8.4 Luxembourg: Influenza Vaccine Market Breakdown, by Distribution Channel

11.3.1.9 Norway: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.9.1 Norway: Influenza Vaccine Market Breakdown, by Type
11.3.1.9.2 Norway: Influenza Vaccine Market Breakdown, by Valency
11.3.1.9.3 Norway: Influenza Vaccine Market Breakdown, by Age Group
11.3.1.9.4 Norway: Influenza Vaccine Market Breakdown, by Distribution Channel

11.3.1.10 Finland: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.10.1 Finland: Influenza Vaccine Market Breakdown, by Type
11.3.1.10.2 Finland: Influenza Vaccine Market Breakdown, by Valency
11.3.1.10.3 Finland: Influenza Vaccine Market Breakdown, by Age Group
11.3.1.10.4 Finland: Influenza Vaccine Market Breakdown, by Distribution Channel

11.3.1.11 Denmark: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.11.1 Denmark: Influenza Vaccine Market Breakdown, by Type
11.3.1.11.2 Denmark: Influenza Vaccine Market Breakdown, by Valency
11.3.1.11.3 Denmark: Influenza Vaccine Market Breakdown, by Age Group
11.3.1.11.4 Denmark: Influenza Vaccine Market Breakdown, by Distribution Channel

11.3.1.12 Sweden: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.12.1 Sweden: Influenza Vaccine Market Breakdown, by Type
11.3.1.12.2 Sweden: Influenza Vaccine Market Breakdown, by Valency
11.3.1.12.3 Sweden: Influenza Vaccine Market Breakdown, by Age Group
11.3.1.12.4 Sweden: Influenza Vaccine Market Breakdown, by Distribution Channel

11.3.1.13 Switzerland: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.13.1 Switzerland: Influenza Vaccine Market Breakdown, by Type
11.3.1.13.2 Switzerland: Influenza Vaccine Market Breakdown, by Valency
11.3.1.13.3 Switzerland: Influenza Vaccine Market Breakdown, by Age Group
11.3.1.13.4 Switzerland: Influenza Vaccine Market Breakdown, by Distribution Channel

11.3.1.14 Austria: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.14.1 Austria: Influenza Vaccine Market Breakdown, by Type
11.3.1.14.2 Austria: Influenza Vaccine Market Breakdown, by Valency
11.3.1.14.3 Austria: Influenza Vaccine Market Breakdown, by Age Group
11.3.1.14.4 Austria: Influenza Vaccine Market Breakdown, by Distribution Channel

11.3.1.15 Greece: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.15.1 Greece: Influenza Vaccine Market Breakdown, by Type
11.3.1.15.2 Greece: Influenza Vaccine Market Breakdown, by Valency
11.3.1.15.3 Greece: Influenza Vaccine Market Breakdown, by Age Group
11.3.1.15.4 Greece: Influenza Vaccine Market Breakdown, by Distribution Channel

11.3.1.16 Portugal: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.16.1 Portugal: Influenza Vaccine Market Breakdown, by Type
11.3.1.16.2 Portugal: Influenza Vaccine Market Breakdown, by Valency
11.3.1.16.3 Portugal: Influenza Vaccine Market Breakdown, by Age Group
11.3.1.16.4 Portugal: Influenza Vaccine Market Breakdown, by Distribution Channel

11.3.1.17 Russia: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.17.1 Russia: Influenza Vaccine Market Breakdown, by Type
11.3.1.17.2 Russia: Influenza Vaccine Market Breakdown, by Valency
11.3.1.17.3 Russia: Influenza Vaccine Market Breakdown, by Age Group
11.3.1.17.4 Russia: Influenza Vaccine Market Breakdown, by Distribution Channel

11.3.1.18 Poland: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.18.1 Poland: Influenza Vaccine Market Breakdown, by Type
11.3.1.18.2 Poland: Influenza Vaccine Market Breakdown, by Valency
11.3.1.18.3 Poland: Influenza Vaccine Market Breakdown, by Age Group
11.3.1.18.4 Poland: Influenza Vaccine Market Breakdown, by Distribution Channel

11.3.1.19 Romania: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.19.1 Romania: Influenza Vaccine Market Breakdown, by Type
11.3.1.19.2 Romania: Influenza Vaccine Market Breakdown, by Valency
11.3.1.19.3 Romania: Influenza Vaccine Market Breakdown, by Age Group
11.3.1.19.4 Romania: Influenza Vaccine Market Breakdown, by Distribution Channel

11.3.1.20 Czech Republic: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.20.1 Czech Republic: Influenza Vaccine Market Breakdown, by Type
11.3.1.20.2 Czech Republic: Influenza Vaccine Market Breakdown, by Valency
11.3.1.20.3 Czech Republic: Influenza Vaccine Market Breakdown, by Age Group
11.3.1.20.4 Czech Republic: Influenza Vaccine Market Breakdown, by Distribution Channel

11.3.1.21 Ukraine: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.21.1 Ukraine: Influenza Vaccine Market Breakdown, by Type
11.3.1.21.2 Ukraine: Influenza Vaccine Market Breakdown, by Valency
11.3.1.21.3 Ukraine: Influenza Vaccine Market Breakdown, by Age Group
11.3.1.21.4 Ukraine: Influenza Vaccine Market Breakdown, by Distribution Channel

11.3.1.22 Slovakia: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.22.1 Slovakia: Influenza Vaccine Market Breakdown, by Type
11.3.1.22.2 Slovakia: Influenza Vaccine Market Breakdown, by Valency
11.3.1.22.3 Slovakia: Influenza Vaccine Market Breakdown, by Age Group
11.3.1.22.4 Slovakia: Influenza Vaccine Market Breakdown, by Distribution Channel

11.3.1.23 Bulgaria: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.23.1 Bulgaria: Influenza Vaccine Market Breakdown, by Type
11.3.1.23.2 Bulgaria: Influenza Vaccine Market Breakdown, by Valency
11.3.1.23.3 Bulgaria: Influenza Vaccine Market Breakdown, by Age Group
11.3.1.23.4 Bulgaria: Influenza Vaccine Market Breakdown, by Distribution Channel

11.4 Asia-Pacific

11.4.1 Influenza Vaccine Market Breakdown, by Key Country, 2026 and 2033 (%)
11.4.1.1 Influenza Vaccine Market – Revenue and Forecast Analysis – by Country
11.4.1.1 China: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.1.1 China: Influenza Vaccine Market Breakdown, by Type
11.4.1.1.2 China: Influenza Vaccine Market Breakdown, by Valency
11.4.1.1.3 China: Influenza Vaccine Market Breakdown, by Age Group
11.4.1.1.4 China: Influenza Vaccine Market Breakdown, by Distribution Channel

11.4.1.2 Japan: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.2.1 Japan: Influenza Vaccine Market Breakdown, by Type
11.4.1.2.2 Japan: Influenza Vaccine Market Breakdown, by Valency
11.4.1.2.3 Japan: Influenza Vaccine Market Breakdown, by Age Group
11.4.1.2.4 Japan: Influenza Vaccine Market Breakdown, by Distribution Channel

11.4.1.3 South Korea: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.3.1 South Korea: Influenza Vaccine Market Breakdown, by Type
11.4.1.3.2 South Korea: Influenza Vaccine Market Breakdown, by Valency
11.4.1.3.3 South Korea: Influenza Vaccine Market Breakdown, by Age Group
11.4.1.3.4 South Korea: Influenza Vaccine Market Breakdown, by Distribution Channel

11.4.1.4 India: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.4.1 India: Influenza Vaccine Market Breakdown, by Type
11.4.1.4.2 India: Influenza Vaccine Market Breakdown, by Valency
11.4.1.4.3 India: Influenza Vaccine Market Breakdown, by Age Group
11.4.1.4.4 India: Influenza Vaccine Market Breakdown, by Distribution Channel

11.4.1.5 Australia: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.5.1 Australia: Influenza Vaccine Market Breakdown, by Type
11.4.1.5.2 Australia: Influenza Vaccine Market Breakdown, by Valency
11.4.1.5.3 Australia: Influenza Vaccine Market Breakdown, by Age Group
11.4.1.5.4 Australia: Influenza Vaccine Market Breakdown, by Distribution Channel

11.4.1.6 New Zealand: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.6.1 New Zealand: Influenza Vaccine Market Breakdown, by Type
11.4.1.6.2 New Zealand: Influenza Vaccine Market Breakdown, by Valency
11.4.1.6.3 New Zealand: Influenza Vaccine Market Breakdown, by Age Group
11.4.1.6.4 New Zealand: Influenza Vaccine Market Breakdown, by Distribution Channel

11.4.1.7 Indonesia: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.7.1 Indonesia: Influenza Vaccine Market Breakdown, by Type
11.4.1.7.2 Indonesia: Influenza Vaccine Market Breakdown, by Valency
11.4.1.7.3 Indonesia: Influenza Vaccine Market Breakdown, by Age Group
11.4.1.7.4 Indonesia: Influenza Vaccine Market Breakdown, by Distribution Channel

11.4.1.8 Malaysia: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.8.1 Malaysia: Influenza Vaccine Market Breakdown, by Type
11.4.1.8.2 Malaysia: Influenza Vaccine Market Breakdown, by Valency
11.4.1.8.3 Malaysia: Influenza Vaccine Market Breakdown, by Age Group
11.4.1.8.4 Malaysia: Influenza Vaccine Market Breakdown, by Distribution Channel

11.4.1.9 Philippines: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.9.1 Philippines: Influenza Vaccine Market Breakdown, by Type
11.4.1.9.2 Philippines: Influenza Vaccine Market Breakdown, by Valency
11.4.1.9.3 Philippines: Influenza Vaccine Market Breakdown, by Age Group
11.4.1.9.4 Philippines: Influenza Vaccine Market Breakdown, by Distribution Channel

11.4.1.10 Singapore: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.10.1 Singapore: Influenza Vaccine Market Breakdown, by Type
11.4.1.10.2 Singapore: Influenza Vaccine Market Breakdown, by Valency
11.4.1.10.3 Singapore: Influenza Vaccine Market Breakdown, by Age Group
11.4.1.10.4 Singapore: Influenza Vaccine Market Breakdown, by Distribution Channel

11.4.1.11 Thailand: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.11.1 Thailand: Influenza Vaccine Market Breakdown, by Type
11.4.1.11.2 Thailand: Influenza Vaccine Market Breakdown, by Valency
11.4.1.11.3 Thailand: Influenza Vaccine Market Breakdown, by Age Group
11.4.1.11.4 Thailand: Influenza Vaccine Market Breakdown, by Distribution Channel

11.4.1.12 Vietnam: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.12.1 Vietnam: Influenza Vaccine Market Breakdown, by Type
11.4.1.12.2 Vietnam: Influenza Vaccine Market Breakdown, by Valency
11.4.1.12.3 Vietnam: Influenza Vaccine Market Breakdown, by Age Group
11.4.1.12.4 Vietnam: Influenza Vaccine Market Breakdown, by Distribution Channel

11.4.1.13 Taiwan: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.13.1 Taiwan: Influenza Vaccine Market Breakdown, by Type
11.4.1.13.2 Taiwan: Influenza Vaccine Market Breakdown, by Valency
11.4.1.13.3 Taiwan: Influenza Vaccine Market Breakdown, by Age Group
11.4.1.13.4 Taiwan: Influenza Vaccine Market Breakdown, by Distribution Channel

11.4.1.14 Bangladesh: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.14.1 Bangladesh: Influenza Vaccine Market Breakdown, by Type
11.4.1.14.2 Bangladesh: Influenza Vaccine Market Breakdown, by Valency
11.4.1.14.3 Bangladesh: Influenza Vaccine Market Breakdown, by Age Group
11.4.1.14.4 Bangladesh: Influenza Vaccine Market Breakdown, by Distribution Channel

11.5 South and Central America

11.5.1 Influenza Vaccine Market Breakdown, by Key Country, 2026 and 2033 (%)
11.5.1.1 Influenza Vaccine Market – Revenue and Forecast Analysis – by Country
11.5.1.1 Brazil: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.1.1 Brazil: Influenza Vaccine Market Breakdown, by Type
11.5.1.1.2 Brazil: Influenza Vaccine Market Breakdown, by Valency
11.5.1.1.3 Brazil: Influenza Vaccine Market Breakdown, by Age Group
11.5.1.1.4 Brazil: Influenza Vaccine Market Breakdown, by Distribution Channel

11.5.1.2 Argentina: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.2.1 Argentina: Influenza Vaccine Market Breakdown, by Type
11.5.1.2.2 Argentina: Influenza Vaccine Market Breakdown, by Valency
11.5.1.2.3 Argentina: Influenza Vaccine Market Breakdown, by Age Group
11.5.1.2.4 Argentina: Influenza Vaccine Market Breakdown, by Distribution Channel

11.5.1.3 Chile: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.3.1 Chile: Influenza Vaccine Market Breakdown, by Type
11.5.1.3.2 Chile: Influenza Vaccine Market Breakdown, by Valency
11.5.1.3.3 Chile: Influenza Vaccine Market Breakdown, by Age Group
11.5.1.3.4 Chile: Influenza Vaccine Market Breakdown, by Distribution Channel

11.5.1.4 Colombia: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.4.1 Colombia: Influenza Vaccine Market Breakdown, by Type
11.5.1.4.2 Colombia: Influenza Vaccine Market Breakdown, by Valency
11.5.1.4.3 Colombia: Influenza Vaccine Market Breakdown, by Age Group
11.5.1.4.4 Colombia: Influenza Vaccine Market Breakdown, by Distribution Channel

11.5.1.5 Peru: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.5.1 Peru: Influenza Vaccine Market Breakdown, by Type
11.5.1.5.2 Peru: Influenza Vaccine Market Breakdown, by Valency
11.5.1.5.3 Peru: Influenza Vaccine Market Breakdown, by Age Group
11.5.1.5.4 Peru: Influenza Vaccine Market Breakdown, by Distribution Channel

11.6 Middle East and Africa

11.6.1 Influenza Vaccine Market Breakdown, by Key Country, 2026 and 2033 (%)
11.6.1.1 Influenza Vaccine Market – Revenue and Forecast Analysis – by Country
11.6.1.1 Saudi Arabia: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.1.1 Saudi Arabia: Influenza Vaccine Market Breakdown, by Type
11.6.1.1.2 Saudi Arabia: Influenza Vaccine Market Breakdown, by Valency
11.6.1.1.3 Saudi Arabia: Influenza Vaccine Market Breakdown, by Age Group
11.6.1.1.4 Saudi Arabia: Influenza Vaccine Market Breakdown, by Distribution Channel

11.6.1.2 United Arab Emirates: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.2.1 United Arab Emirates: Influenza Vaccine Market Breakdown, by Type
11.6.1.2.2 United Arab Emirates: Influenza Vaccine Market Breakdown, by Valency
11.6.1.2.3 United Arab Emirates: Influenza Vaccine Market Breakdown, by Age Group
11.6.1.2.4 United Arab Emirates: Influenza Vaccine Market Breakdown, by Distribution Channel

11.6.1.3 Kuwait: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.3.1 Kuwait: Influenza Vaccine Market Breakdown, by Type
11.6.1.3.2 Kuwait: Influenza Vaccine Market Breakdown, by Valency
11.6.1.3.3 Kuwait: Influenza Vaccine Market Breakdown, by Age Group
11.6.1.3.4 Kuwait: Influenza Vaccine Market Breakdown, by Distribution Channel

11.6.1.4 Bahrain: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.4.1 Bahrain: Influenza Vaccine Market Breakdown, by Type
11.6.1.4.2 Bahrain: Influenza Vaccine Market Breakdown, by Valency
11.6.1.4.3 Bahrain: Influenza Vaccine Market Breakdown, by Age Group
11.6.1.4.4 Bahrain: Influenza Vaccine Market Breakdown, by Distribution Channel

11.6.1.5 Qatar: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.5.1 Qatar: Influenza Vaccine Market Breakdown, by Type
11.6.1.5.2 Qatar: Influenza Vaccine Market Breakdown, by Valency
11.6.1.5.3 Qatar: Influenza Vaccine Market Breakdown, by Age Group
11.6.1.5.4 Qatar: Influenza Vaccine Market Breakdown, by Distribution Channel

11.6.1.6 Oman: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.6.1 Oman: Influenza Vaccine Market Breakdown, by Type
11.6.1.6.2 Oman: Influenza Vaccine Market Breakdown, by Valency
11.6.1.6.3 Oman: Influenza Vaccine Market Breakdown, by Age Group
11.6.1.6.4 Oman: Influenza Vaccine Market Breakdown, by Distribution Channel

11.6.1.7 Turkiye: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.7.1 Turkiye: Influenza Vaccine Market Breakdown, by Type
11.6.1.7.2 Turkiye: Influenza Vaccine Market Breakdown, by Valency
11.6.1.7.3 Turkiye: Influenza Vaccine Market Breakdown, by Age Group
11.6.1.7.4 Turkiye: Influenza Vaccine Market Breakdown, by Distribution Channel

11.6.1.8 South Africa: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.8.1 South Africa: Influenza Vaccine Market Breakdown, by Type
11.6.1.8.2 South Africa: Influenza Vaccine Market Breakdown, by Valency
11.6.1.8.3 South Africa: Influenza Vaccine Market Breakdown, by Age Group
11.6.1.8.4 South Africa: Influenza Vaccine Market Breakdown, by Distribution Channel

11.6.1.9 Egypt: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.9.1 Egypt: Influenza Vaccine Market Breakdown, by Type
11.6.1.9.2 Egypt: Influenza Vaccine Market Breakdown, by Valency
11.6.1.9.3 Egypt: Influenza Vaccine Market Breakdown, by Age Group
11.6.1.9.4 Egypt: Influenza Vaccine Market Breakdown, by Distribution Channel

11.6.1.10 Nigeria: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.10.1 Nigeria: Influenza Vaccine Market Breakdown, by Type
11.6.1.10.2 Nigeria: Influenza Vaccine Market Breakdown, by Valency
11.6.1.10.3 Nigeria: Influenza Vaccine Market Breakdown, by Age Group
11.6.1.10.4 Nigeria: Influenza Vaccine Market Breakdown, by Distribution Channel

11.6.1.11 Algeria: Influenza Vaccine Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.11.1 Algeria: Influenza Vaccine Market Breakdown, by Type
11.6.1.11.2 Algeria: Influenza Vaccine Market Breakdown, by Valency
11.6.1.11.3 Algeria: Influenza Vaccine Market Breakdown, by Age Group
11.6.1.11.4 Algeria: Influenza Vaccine Market Breakdown, by Distribution Channel

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Sanofi

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 CSL Limited

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 GSK plc

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 AstraZeneca PLC

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Abbott Laboratories

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Pfizer Inc.

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Moderna, Inc.

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Sinovac Biotech Ltd.

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 GC Biopharma Corp.

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 SK bioscience Co., Ltd.

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Access the Full Influenza Vaccine Market Report

Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.

Download Sample Request Customization